Most Read News


KPA requests revocation of registration on 24/7 convenient stores selling drugs

The Korea Pharmaceutical Association(President Chan-Whi Cho, KPA) requested local governments to immediately revoke registration on convenient stores which do not sell drugs for 24/7 even though they are registered to...

‘Inlyta’ applied to national health insurance service this July

‘Inlyta Tab,’ a targeted therapy for renal cancer, will be applied to the national health insurance service this July. Drug prices of Simponi, a rheumatoid arthritis therapy, and Soliris, a paroxysmal nocturnal hemog...

iNtRON Biotechnology acquire U.S. FDA’s Orphan Drug Designation for Endolysin

iNtRON Biotechnology(CEO Kyung-Won Yoon), a new biologic developing company, announced on the 26th that its currently-developing bacillus anthracis based on endolysin called ‘N-Rephasin BAL200(hereinafter referring to...

Last year, amount of medicinal drugs imported and exported reaches to KRW 10 billion

The Korea’s amount of medicinal drugs imported and exported was USD 9.61 billion, close to KRW 10 billion, increased by 11.6% year-on-year. According to the Korea Health Industry Development Institute’s analysis resu...

KPDA to actively get ready for low margin and serial number system

The Korea Pharmaceutical Distribution Association(KPDA) will intensively seek for active measures about current pending issues, such as low margins from pharmaceutical companies, the serial number system and legislati...

Merck to focus on cancer immunotherapy, multiple sclerosis and infertility

Merck Korea, a Korean branch of Merch, the global life science company, announced a promise to lead the future industry by focusing on ‘cancer immunotherapy,’ ‘multiple sclerosis’ and ‘infertility’ in the pharmaceutic...

Rare and/or incurable disease patients will be allowed to import narcotics for self-care

A system will be revised for rare and/or incurable disease patients to import narcotics or psychotomimetic agents on their own if necessary for self-care. The Ministry of Food and Drug Safety(MFDS), on the 5th, pre-a...

Brinks Global signs MOU with DKSH for drug market

Brinks Global, a secured distribution company for pharmaceutical products and valuables, announced the company signed a memorandum of understanding(MOU) for introduction to the drug market and cooperation in secured d...

Last meeting for adjustment of the emergency household medicine list

The deliberative committee for adjustment of the emergency household medicine list, which had been carried out for a year and delayed for 6 months, is getting closer to the final meeting. In the circumstance where it...

MFDS extends range of contact drug manufacturing services for biologics

The range of subjects to outsource production of biologics will be extended, and they will specially acquire product approval if these biologics are orphan drugs. The Ministry of Food and Drug Safety(MFDS) recently r...

When the distribution industry will be able to balance payments with pharmas for drug price cuts?

While the government has continue to show a mood to cut drug prices, the issue with balancing accounts has shown no sign to be addressed. According to the pharmaceutical distribution industry, pharmaceutical companie...

“Samsung Biologics might become touchstone for financial reform”

It was argued that Samsung Biologics with accounting fraud and IPO legitimacy issues might become the ‘touchstone for financial reform.’ Won-Gu Ahn, former Director of the Daegu Regional Tax Service, expressed overal...

A number of 24/7 convenient stores do not sell emergency household medicines at night

According to the research result on the emergency household medicines sold at 24/7 convenient stores, there a number of convenient stores which do not manage these sales well at night. Korea Institute for Pharmaceuti...

Pharma industry highly concerns about conflicts between medical and pharmaceutical associations over ‘Valsartan’

The pharmaceutical industry has shown high interests in recruiting the chairman of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA). In the circumstance where the antihypertensive ‘Valsartan’ ...

Pharmaceutical Product Approval Renewal to select subject in safety and efficacy

As the pharmaceutical product approval renewal system started last year, pharmaceutical products will be selectively evaluated if necessary in safety and efficacy, instead of periodic drug evaluations. The Ministry o...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.